Literature DB >> 27670230

Thyroid cancer: BRAF and/or TERT mutations increase mortality.

Peter Sidaway.   

Abstract

Entities:  

Year:  2016        PMID： 27670230     DOI： 10.1038/nrclinonc.2016.158

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer: Genetic Duet of BRAF and TERT Promoter Mutations in Thyroid Cancer Mortality.

Authors:  Rengyun Liu; Justin Bishop; Guangwu Zhu; Tao Zhang; Paul W Ladenson; Mingzhao Xing
Journal:  JAMA Oncol       Date:  2017-02-01       Impact factor: 31.777
  1 in total
  3 in total

1.  Preliminary screening and analysis of metastasis-related lncRNA and co-expressed papillary thyroid carcinoma mRNA.

Authors:  Ming-Hua Ge; Lie-Hao Jiang; Qing-Liang Wen; Zhuo Tan; Chao Chen; Chuan-Ming Zheng; Xin Zhu; Jia-Wen Chen; Zi-Yu Zhu; Xiu-Jun Cai
Journal:  Oncol Lett       Date:  2018-07-05       Impact factor: 2.967

2.  BRAFV600E mutation test on fine-needle aspiration specimens of thyroid nodules: Clinical correlations for 4600 patients.

Authors:  Huang Chen; Aiping Song; Ye Wang; Yifan He; Jie Tong; Jinxi Di; Chun Li; Zhongren Zhou; Xiaopin Cai; Dingrong Zhong; Jiping Da
Journal:  Cancer Med       Date:  2021-12-01       Impact factor: 4.452

3.  Disease-Specific Mortality of Differentiated Thyroid Cancer Patients in Korea: A Multicenter Cohort Study.

Authors:  Min Ji Jeon; Won Gu Kim; Tae Hyuk Kim; Hee Kyung Kim; Bo Hyun Kim; Hyon Seung Yi; Eun Sook Kim; Hosu Kim; Young Nam Kim; Eun Heui Kim; Tae Yong Kim; Sun Wook Kim; Ho Cheol Kang; Jae Hoon Chung; Young Kee Shong; Won Bae Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2017-11-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.